Joseph A Kozlowski

This inventor holds 104 USPTO granted patents and 24 published patent applications, plus 2 CIPO patents and 60 EPO patents, primarily in Pharmaceutical Chemistry (CPC class A61K45-06). Top assignees: Merck Sharp + Dohme Corp., Schering Corporation, Pharmacopeia Drug Discovery, Inc.. Active years: 1993-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph A Kozlowski. Retrieved from https://idiyas.com/inventor/joseph-a-kozlowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 104 (Patent Applications = 24)

% Patents Active = 80.8

CIPO Patents = 2

EPO Patents = 60 (Patent Applications = 56)

Average Co-Inventor Count = 8.2

ph-index = 17

Forward Citations = 883(Granted Patents)

Forward Citations (Not Self Cited) = 778(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Plainsboro, NJ (US) (1993 - 1996)
Summit, NJ (US) (2016)
Princeton, NJ (US) (1999 - 2024)

Company Filing History:

52 out of 2,405

Merck Sharp + Dohme Corp.

Pharmacopeia Drug Discovery, Inc.

Msd R&d (China) Co., Ltd.

Southern Research Institute

patents

8. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2025

Loading Chart...

Areas of Expertise:

HIV Inhibitors

Btk Inhibitors

ERK Inhibitors

Indoleamine 2,3-Dioxygenase

Histone Deacetylase

Antiviral Compounds

Oxazolidinone Compounds

Tetracyclic Compounds

Pyrazole Compounds

Neurodegeneration

Cancer Treatment

Inflammation

104 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12365674 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection (2025-07-22),

2. 12365656 - Oxazolidinone compounds and methods of use thereof as antibacterial agents (2025-07-22),

3. 12331044 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection (2025-06-17),

4. 12281109 - Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes (2025-04-21),

5. 12264134 - Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2025-04-01),

6. 12091405 - Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors (2024-09-17),

7. 11976069 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection (2024-05-07),

8. 11034661 - Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors (2021-06-15),

9. 10988487 - Substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-04-27),

10. 10945771 - Azabicyclo[4.1.0]heptane allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-03-16),

11. 10927086 - Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-02-23),

12. 10787441 - Hepatitis C virus inhibitors (2020-09-29),

13. 10759805 - Compounds that are ERK inhibitors (2020-09-01),

14. 10738062 - Chromane-substituted tetracyclic compounds and uses thereof for the treatment of viral diseases (2020-08-11),

15. 10646494 - Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases (2020-05-12),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will now prepare an article about inventor Joseph A Kozlowski based on the data provided.

Title: Spotlight on Inventor Joseph A Kozlowski

Introduction:

Joseph A Kozlowski is a prolific inventor based in Summit, NJ (US) with an impressive track record of 97 patents to his name. His innovative work has significantly contributed to the field of pharmaceuticals and medical research.

Latest Patents:

Among his recent patents, Joseph A Kozlowski has developed "Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors." These compounds have shown promise in the treatment and prevention of IDO-associated diseases and disorders, making them a valuable addition to the pharmaceutical industry.

Career Highlights:

Joseph A Kozlowski has honed his skills and expertise while working at esteemed companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His contributions to these organizations have been invaluable in pushing the boundaries of scientific innovation in the healthcare sector.

Collaborations:

Throughout his career, Joseph A Kozlowski has collaborated with talented individuals in the field. Notable co-workers include Neng-Yang Shih and Wensheng Yu, whose combined efforts have led to groundbreaking advancements in pharmaceutical research.

Conclusion:

Inventor Joseph A Kozlowski's dedication to innovation and his numerous patents demonstrate his commitment to improving healthcare through cutting-edge solutions. His collaborative spirit and relentless pursuit of scientific excellence continue to inspire fellow researchers and inventors in the industry.

If you need more information or details about Joseph A Kozlowski's work or any other inventor, feel free to explore our website idiyas.com for comprehensive insights into the world of innovations and inventions.

Profile summary based on public USPTO records.